These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Histoenzymologic modifications induced by perhexiline maleate in human liver]. Lageron A Med Chir Dig; 1979; 8(5):415-7. PubMed ID: 534019 [No Abstract] [Full Text] [Related]
10. [The liver and perhexiline maleate]. Beaugrand M; Callard P; Lageron A Med Chir Dig; 1979; 8(5):411-3. PubMed ID: 534018 [No Abstract] [Full Text] [Related]
11. [Cirrhogenic hepatitis due to perhexiline maleate: general review based upon one new case with ultrastructural study (author's transl)]. Bertrand L; Baldet P; Blanc F; Puyeo J Ann Med Interne (Paris); 1978 Oct; 129(10):565-74. PubMed ID: 369426 [TBL] [Abstract][Full Text] [Related]
12. [Drug monitoring and liver diseases induced by perhexiline maleate]. Paliard P; Evreux JC; Léry N Gastroenterol Clin Biol; 1981 May; 5(5):564-6. PubMed ID: 7018984 [No Abstract] [Full Text] [Related]
18. Cirrhosis of the liver following therapy with perhexiline maleate. Hay DR; Gwynne JF N Z Med J; 1983 Mar; 96(728):202-4. PubMed ID: 6572824 [TBL] [Abstract][Full Text] [Related]
19. [Diffuse polymorphous inclusions in a patient treated with perhexiline maleate (author's transl)]. Hauw JJ; Singer B; Poupon R; Lecomte D; de Saint-Maur PP; Lageron A; Pollet S Nouv Presse Med; 1978 Mar; 7(10):817-20. PubMed ID: 205835 [TBL] [Abstract][Full Text] [Related]
20. Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation. Robin MA; Descatoire V; Pessayre D; Berson A Toxicol In Vitro; 2008 Sep; 22(6):1511-9. PubMed ID: 18603402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]